Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT PAD
NCT06686121Phase 3Recruiting
- Sponsor
- Northwestern University
- Start
- Aug 2025
- Primary completion
- Feb 2032
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in peripheral artery disease (PAD) (4 arms), sponsored by Northwestern University. Primary endpoint: Six-Minute Walk Distance at 6 months. Started Aug 2025; status: recruiting.
02
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT06686121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06686121.